Hepatic effects of ketamine administration for 2 weeks in rats

Human and Experimental Toxicology

Volumn 33, Issue 1, 2014, Pages 32-40

  Kalkan, Y ^a   Tomak, Y ^a   Altuner, D ^a   Tumkaya, L ^a   Bostan, H ^b   Yilmaz, A ^a   Unal, D ^c   Kara, A ^c   Turan, A ^d  

^a RECEP TAYYIP ERDOGAN UNIVERSITY   (Turkey)

^b Institute of Forensic Medicine   (Turkey)

^c ATATURK UNIVERSITY   (Turkey)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Hepatotoxicity; ketamine

Indexed keywords

CALCINEURIN; CALCIUM; GLUCOSE; KETAMINE; MAGNESIUM; POTASSIUM; SODIUM CHLORIDE;

ANIMAL CELL; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; ELECTRON MICROSCOPY; GLUCOSE BLOOD LEVEL; IMMUNOHISTOLOGY; IMMUNOREACTIVITY; LIVER CELL; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER HISTOLOGY; LIVER TOXICITY; MAGNESIUM BLOOD LEVEL; MALE; MITOCHONDRION; NONHUMAN; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RAT; ROUGH ENDOPLASMIC RETICULUM;

HEPATOTOXICITY; KETAMINE;

ANALGESICS; ANESTHETICS, DISSOCIATIVE; ANIMALS; APOPTOSIS; CALCINEURIN; CHRONIC PAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-INDUCED LIVER INJURY; ENDOPLASMIC RETICULUM, ROUGH; INJECTIONS, INTRAPERITONEAL; KETAMINE; LIVER; MALE; MITOCHONDRIA, LIVER; NECROSIS; PAIN MANAGEMENT; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; VACUOLES;

EID: 84890855438     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327112472990     Document Type: Article

References (38)

1. Patterson DR, Hoflund H, Espey K, Sharar S. Pain management. Burns. 2004 ; 30: A10 - A15 (Pubitemid 39536068)
2. Trupkovic T, Kinn M, Kleinschmidt S. Analgesia and sedation in the intensive care of burn patients: results of a European survey. J Intensive Care Med. 2011 ; 26: 397-407
3. Dahan A, Olofsen E, Sigtermans M, Noppers I, Niesters M, Aarts L, et al. Population pharmacokinetic-pharmacodynamic modeling of ketamine-induced pain relief of chronic pain. Eur J Pain. 2011 ; 15: 258-267
4. Craven R. Ketamine. Anaesthesia. 2007 ; 62: 48-53 (Pubitemid 47610603)
5. Burmeister-Rother R, Streatfeild KA, Yoo MC. Convulsions following ketamine and atropine. Anaesthesia. 1993 ; 48: 82
6. Persson J. Wherefore ketamine?. Curr Opin Anaesthesiol. 2010 ; 23: 455-460
7. White PF, Schüttler J, Shafer A, Stanski DR, Horai Y, Trevor AJ. Comparative pharmacology of the ketamine isomers. Br J Anaesth. 1985 ; 57: 197-203
8. Murdoch CJ, Crooks BA, Miller CD. Effect of the addition of ketamine to morphine in patient-controlled analgesia. Anaesthesia. 2002 ; 57: 484-488 (Pubitemid 34477047)
9. Haas DA, Harper DG. Ketamine: a review of its pharmacologic properties and use in ambulatory anesthesia. Anesth Prog. 1992 ; 39: 61-68 (Pubitemid 23173642)
10. Kim EM, Lee JS, Choi SK, Lim MA, Chung HS. Analysis of ketamine and norketamine in urine by automatic solid-phase extraction (SPE) and positive ion chemical ionization-gas chromatography-mass spectrometry (PCI-GC-MS). Forensic Sci Int. 2008 ; 174: 197-202
11. Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Engl J Med. 2006 ; 354: 731-739 (Pubitemid 43247143)
12. Rofael HZ. Effect of ketamine pretreatment on cocaine-mediated hepatotoxicity in rats. Toxicol Lett. 2004 ; 152: 213-222 (Pubitemid 39141166)
13. Saranteas T, Zotos N, Lolis E, Stranomiti J, Mourouzis C, Chantzi C, et al. Mechanisms of ketamine action on lipid metabolism in rats. Eur J Anaesthesiol. 2005 ; 22: 222-226 (Pubitemid 40694737)
14. Lo RS, Krishnamoorthy R, Freeman JG, Austin AS. Cholestasis and biliary dilatation associated with chronic ketamine abuse: a case series. Singapore Med J. 2011 ; 52: e52 - e55
15. Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Engl J Med. 2006 ; 354: 731-739 (Pubitemid 43247143)
16. Kane AB, Young EE, Schanne FA, Farber JL. Calcium dependence of phalloidin-induced liver cell death. Proc Natl Acad Sci USA. 1980 ; 77: 1177-1180 (Pubitemid 10101399)
17. Chang HC, Chen TL, Chen RM. Cytoskeleton interruption in human hepatoma HepG2 cells induced by ketamine occurs possibly through suppression of calcium mobilization and mitochondrial function. Drug Metab Dispos. 2009 ; 37: 24-31
18. Chen JT, Chen RM. Mechanisms of ketamine-involved regulation of cytochrome P450 gene expression. Expert Opin Drug Metab Toxicol. 2010 ; 6: 273-281
19. Macian F. NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol. 2005 ; 5: 472-484 (Pubitemid 40835035)
20. Lipskaia L, Lompré AM. Alteration in temporal kinetics of Ca2+ signaling and control of growth and proliferation. Biol Cell. 2004 ; 96: 55-68 (Pubitemid 38240399)
21. Zhao Y, Tozawa Y, Iseki R, Mukai M, Iwata M. Calcineurin activation protects T cells from glucocorticoid-induced apoptosis. J Immunol. 1995 ; 154: 6346-6354
22. Could ketamine HCl cause pancreatitis?http://www.ehealthme.com/ds/ ketamine+hcl/pancreatitis(accessed 04 April 2012).
23. Chan WH, Sun WZ, Ueng TH. Induction of rat hepatic cytochrome P-450 by ketamine and its toxicological implications. J Toxicol Environ Health A. 2005 ; 68: 1581-1597
24. Noppers IM, Niesters M, Aarts LP, Bauer MC, Drewes AM, Dahan A, et al. Drug-induced liver injury following a repeated course of ketamine treatment for chronic pain in CRPS type 1 patients: a report of 3 cases. Pain. 2011 ; 152: 2173-2178
25. Could ketamine HCl cause liver disorder?http://www.ehealthme.com/ds/ ketamine+hcl/liver+disorder(accessed 04 April 2012).
26. Wong SW, Lee KF, Wong J, Ng WW, Cheung YS, Lai PB. Dilated common bile ducts mimicking choledochal cysts in ketamine abusers. Hong Kong Med J. 2009 ; 15: 53-56
27. Pai A, Heining M. Ketamine. Continuing education in anaesthesia. Crit Care Pain. 2007 ; 7: 59-53
28. DeClue AE, Cohn LA, Lechner ES, Bryan ME, Dodam JR. Effects of subanesthetic doses of ketamine on hemodynamic and immunologic variables in dogs with experimentally induced endotoxemia. Am J Vet Res. 2008 ; 69: 228-232 (Pubitemid 351278690)
29. Braun S, Gaza N, Werdehausen R, Hermanns H, Bauer I, Durieux ME, et al. Ketamine induces apoptosis via the mitochondrial pathway in human lymphocytes and neuronal cells. Br J Anaesth. 2010 ; 105: 347-354
30. Wai MS, Chan WM, Zhang AQ, Wu Y, Yew DT. Long-term ketamine and ketamine plus alcohol treatments produced damages in liver and kidney. Hum Exp Toxicol. 2012 ; 31: 877-886
31. Noppers IM, Niesters M, Aarts LP, Bauer MC, Drewes AM, Dahan A, et al. Drug-induced liver injury following a repeated course of ketamine treatment for chronic pain in CRPS type 1 patients: a report of 3 cases. Pain. 2011 ; 152 (9). 2173-2178
32. Shibasaki F, McKeon F. Calcineurin functions in Ca(2+)-activated cell death in mammalian cells. J Cell Biol. 1995 ; 131: 735-743
33. Gal TJ, Malit LA. The influence of ketamine induction on potassium changes and fasciculations following suxamethonium. Br J Anaesth. 1972 ; 44: 1077-1080
34. Gal TJ, Malit LA. The influence of ketamine induction on potassium changes and fasciculations following suxamethonium. Br J Anaesth. 1972 ; 44 (10). 1077-80
35. Sharma I, Sharma VP, Sen N. Effect of ketamine on blood sugar and liver functions. Indian J Anaesth. 1985 ; 33: 29-30
36. Saha JK, Xia J, Grondin JM, Engle SK, Jakubowski JA. Acute hyperglycemia induced by ketamine/xylazine anesthesia in rats: mechanisms and implications for preclinical models. Exp Biol Med (Maywood). 2005 ; 230 (10). 777-84 (Pubitemid 41565948)
37. Sinner B, Graf BM. Ketamine. Handbook of experimental pharmacology. Handb Exp Pharmacol. 2008 ; 182: 313-33
38. Smiler KL, Stein S, Hrapkiewicz KL, Hiben JR. Tissue response to intramuscular and intraperitoneal injections of ketamine and xylazine in rats. Lab Anim Sci. 1990 ; 40: 60-64 (Pubitemid 20061883)